Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:09 AM UTC
| NCT Number | NCT06016738 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 510 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Olema Pharmaceuticals, Inc. |
| Last Updated on CT.gov | March 13, 2026 (Mar 13, 2026) |
As of July 17, 2026: Clinical trial NCT06016738 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 47 locations across the United States. The study is sponsored by Olema Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06016738 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06016738 was last updated Mar 13, 2026 (March 13, 2026). HelloStudys verifies this status automatically.